The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.
Continue Reading
News Source: www.sciencenews.org

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.
News Source: www.sciencenews.org

Cross Country Healthcare (NASDAQ: CCRN), a leader in workforce solutions and tech-enabled staffing, recruitment and advisory services, today released its fourth annual survey, “Beyond the Bedside: The State of Nursing in 2025” report. In partnership with Florida Atlantic University’s Christine E. Lynn College of Nursing, the study paints a sobering picture of a profession at a breaking point — where stress, burnout and chronic short staffing continue to jeopardize the well-being of nurses…
News Source: www.sciencedaily.com

Cholera kills thousands of people and infects hundreds of thousands every year — and cases have spiked in recent years, leaving governments with an urgent need to find the best ways to control outbreaks.
Current public health guidelines discourage treating cholera with antibiotics in all but the most severe cases, to reduce the risk that the disease will evolve resistance to the best treatments we have.
But recent disease modeling research from University of Utah Health challenges that…
News Source: www.sciencedaily.com

Every second counts when it comes to detecting and treating heart attacks. That’s where a new technology from the University of Mississippi comes in to identify heart attacks faster and more accurately than traditional methods.
In a study published in Intelligent Systems, Blockchain and Communication Technologies, electrical and computer engineering assistant professor Kasem Khalil shows that a new technology developed at his lab could improve heart attack detection methods without…
News Source: www.sciencedaily.com

From 2010 to 2020, breast cancer deaths among women ages 20-49 declined significantly across all breast cancer subtypes and racial/ethnic groups, with marked declines starting after 2016, according to an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) registry presented at the American Association for Cancer Research (AACR) Annual Meeting 2025, held April 25-30.
Breast cancer incidence rates in women aged 20 to 49 years have been increasing over the past 20 years…
News Source: www.sciencedaily.com

Australia’s recent move to lower the starting age for bowel (colorectal) cancer screening from 50 down to 45 years old will mean better outcomes — but it will also increase the burden on an already struggling healthcare system, warn Flinders University researchers.
They predict that the expanded screening program will likely lead to an influx of younger adults who will require ongoing surveillance with regular colonoscopies, prompting the team to review current clinical guidelines for at…
News Source: www.sciencedaily.com

Just in time for tick season, new research is shining a light on how animals develop resistance to tick bites, which points toward the possibility of developing more effective vaccines against the tiny, disease-carrying bloodsuckers.
In a study of “acquired tick resistance” among deer mice, rabbits and cattle, researchers at Washington State University found that once host animals were exposed to ticks, they developed resistance to bites that dramatically shrank the tick population going…
News Source: www.sciencedaily.com

Nagoya University researchers in Japan have found that drug effectiveness, alcohol tolerance, and carbohydrate metabolism change with the seasons. Their findings are based on a comprehensive seasonal gene expression map, which investigated over 54,000 genes in 80 tissues in monkeys across one year. The study has implications for drug prescription and precision medicine.
To cope with dynamic seasonal changes in the environment, animals, including humans, have evolved a biological clock that…
News Source: www.sciencedaily.com

Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that people living with HIV need to take lifelong antiretroviral treatment. But some individuals, known as “post-treatment controllers,” are able to maintain an undetectable viral load even after stopping treatment. In a study funded by ANRS Emerging Infectious Diseases (ANRS MIE), scientists from the Institut Pasteur, Inserm and the Paris Public Hospital Network (AP-HP)…
News Source: www.sciencedaily.com

The sensation of controlling one’s body and things in the environment is known as sense of agency (SoA). Not only is SoA pivotal for tasks and well-being in everyday life, but its mechanisms have become increasingly important for the development of human-computer interfaces in new technology. This need has fueled research in this area, in particular to understand how SoA is generated from scratch in unfamiliar environments. Researchers at the University of Tokyo performed experiments…
News Source: www.sciencedaily.com